This topic contains a solution. Click here to go to the answer

Author Question: During the MMPT P&O process, how does a charge controller determine when the MMP has been ... (Read 104 times)

Mr.Thesaxman

  • Hero Member
  • *****
  • Posts: 514
During the MMPT P&O process, how does a charge controller determine when the MMP has been reached?
 
  What will be an ideal response?

Question 2

What is the purpose of the low pass filter in a sine wave inverter?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Athena23

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

The MPPT starts by setting a load value and measuring the module output voltage V1 and the current. The power (P1) at V1 is calculated. Next, the load is increased and power is calculated at several points until it is less than the power calculated at the previous point, indicating that the MMP has been passed. At this point, the MPPT reverses back to the previous voltage and then goes back and forth (oscillates) between the two voltages on either side of the MPP.

Answer to Question 2

The low pass filter removes residual harmonics from the sine wave output.




Athena23

  • Sr. Member
  • ****
  • Posts: 305

 

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library